Intersection	O
of	O
population	O
variation	O
and	O
autoimmunity	O
genetics	O
in	O
human	O
T	O
cell	O
activation	O
.	O


T	O
lymphocyte	O
activation	O
by	O
antigen	O
conditions	O
adaptive	O
immune	O
responses	O
and	O
immunopathologies	O
,	O
but	O
we	O
know	O
little	O
about	O
its	O
variation	O
in	O
humans	O
and	O
its	O
genetic	O
or	O
environmental	O
roots	O
.	O


We	O
analyzed	O
gene	O
expression	O
in	O
CD4	O
(	O
+	O
)	O
T	O
cells	O
during	O
unbiased	O
activation	O
or	O
in	O
T	O
helper	O
17	O
(	O
T	O
(	O
H	O
)	O
17	O
)	O
conditions	O
from	O
348	O
healthy	O
participants	O
representing	O
European	O
,	O
Asian	O
,	O
and	O
African	O
ancestries	O
.	O


We	O
observed	O
interindividual	O
variability	O
,	O
most	O
marked	O
for	O
cytokine	O
transcripts	O
,	O
with	O
clear	O
biases	O
on	O
the	O
basis	O
of	O
ancestry	O
,	O
and	O
following	O
patterns	O
more	O
complex	O
than	O
simple	O
T	O
(	O
H	O
)	O
1	O
/	O
2	O
/	O
17	O
partitions	O
.	O


We	O
identified	O
39	O
genetic	O
loci	O
specifically	O
associated	O
in	O
cis	O
with	O
activated	O
gene	O
expression	O
.	O


We	O
further	O
fine	O
-	O
mapped	O
and	O
validated	O
a	O
single	O
-	O
base	O
variant	O
that	O
modulates	O
YY1	O
binding	O
and	O
the	O
activity	O
of	O
an	O
enhancer	O
element	O
controlling	O
the	O
autoimmune	O
-	O
associated	O
IL2RA	O
gene	O
,	O
affecting	O
its	O
activity	O
in	O
activated	O
but	O
not	O
regulatory	O
T	O
cells	O
.	O


Thus	O
,	O
interindividual	O
variability	O
affects	O
the	O
fundamental	O
immunologic	O
process	O
of	O
T	O
helper	O
activation	O
,	O
with	O
important	O
connections	O
to	O
autoimmune	O
disease	O
.	O
